Corrigendum to: ABCB1 inhibition provides a novel therapeutic target to block TWIST1-induced migration in medulloblastoma

Neurooncol Adv. 2021 Dec 23;3(1):vdab155. doi: 10.1093/noajnl/vdab155. eCollection 2021 Jan-Dec.

¹ Children's Brain Tumour Research Centre, Division of Child Health, Obstetrics and Gynaecology, School of Medicine, University of Nottingham, Nottingham, UK.
² College of Medicine, University of Duhok, Kurdistan, Iraq.
³ Division of Cancer and Stem Cells, School of Medicine, University of Nottingham, Nottingham, UK.
⁴ School of Life Sciences, University of Nottingham, Nottingham, UK.
⁵ Department of Neuropathology, NN Burdenko Neurosurgical Institute, Moscow, Russia.
⁶ Cooperation Unit Neuro-oncology, German Cancer Research Center (DKFZ), Heidelberg, Germany.
⁷ Hopp Children's Cancer Center Heidelberg (KiTZ), German Cancer Research Center (DKFZ), Division of Pediatric Neurooncology and Heidelberg University Hospital, Department of Pediatric Hematology and Oncology, Heidelberg, Germany.

Abstract

[This corrects the article DOI: 10.1093/noajnl/vdab030.].